Compass Minerals International, Inc., provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertilizer solutions under the Protassium+ brand name; turf products used by the turf and ornamental markets, as well as for blends used on golf course greens; organic products; and develops and produces a portfolio of magnesium chloride-based aerial and ground fire retardant products. This segment provides its products to distributors and retailers of crop inputs, as well as growers. The company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003. Compass Minerals International, Inc. was founded in 1844 and is headquartered in Overland Park, Kansas.

Compass Minerals Intl Inc

An update from Eurocommercial Properties NV ( ($NL:ECMPA) ) is now available. Eurocommercial Properties has secured and drawn down a SEK 700 millio...

Eurocommercial Secures SEK 700m Green Loan and Boosts Leasing Across European Malls

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunome (IMNM) and COMPASS Pathways (CMPS) with bul...

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)

Analysts are intrested in these 5 stocks: ( ($WFC) ), ( ($BKR) ), ( ($SLB) ), ( ($HAL) ) and ( ($CMPS) ). Here is a breakdown of their recent


Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Healthequity (HQY), Sarepta Therapeutics (SRPT) and COMPASS Pathw...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Sarepta Therapeutics (SRPT) and COMPASS Pathways (CMPS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS ...

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS Pathways (CMPS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on COMPASS Pathways (CMPS), Meiragtx Holdings (MGTX) ...

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Meiragtx Holdings (MGTX) and Resmed (RMD)

An announcement from COMPASS Pathways ( ($CMPS) ) is now available. On July 7, 2026, Compass Pathways reported 26-week results from Part B of its s...

Compass Pathways reports positive Phase 3 depression results

The latest update is out from Compumedics Limited ( ($AU:CMP) ). Compumedics expects to deliver record FY26 shipped and invoiced revenue of about $...

Compumedics posts record FY26 revenue as SaaS platforms drive growth

Compass Therapeutics ( ($CMPX) ) has shared an announcement. On July 1, 2026, Compass Therapeutics updated its corporate presentation to highlight ...

Compass Showcases Promising Tovecimig Data, Eyes Commercialization

Eurocommercial Properties NV ( ($NL:ECMPA) ) has issued an update. Eurocommercial Properties reported that 18.5% of its shareholders chose to recei...

Eurocommercial boosts equity as 18.5% of shareholders opt for stock dividend

Compass Therapeutics ( ($CMPX) ) has provided an update. On June 22, 2026, Compass Therapeutics, Inc.’s board of directors approved a Second Amende...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CMP	$29.46	+0.37%	296.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CMP	$29.46	+0.4%	296.43K
3
4
5
6

CMP

CMP

Get Compass Minerals Intl Inc Data in Excel

Get Compass Minerals Intl Inc Data in Excel